Relationship between the Finnish Diabetes Risk Score (FINDRISC), vitamin D levels, and insulin resistance in obese subjects

Published:December 01, 2016DOI:


      • LA-FINDRISC was associated with VD plasma concentrations.
      • Subjects with an increased risk of T2D had a greater degree of insulin resistance.
      • VD levels alone may not be sufficient to determine T2D risk.



      To assess the relationship between 25-hydroxyvitamin D [25(OH)D] blood concentrations in subjects with obesity and type 2 diabetes mellitus (T2D) risk according to the Finnish Diabetes Risk Score (FINDRISC) modified for Latin America (LA-FINDRISC).


      This study was conducted in Ciudad Bolívar, Venezuela. Eighty two women and 20 men (53 obese and 49 nonobese), with an average age of 42.6 ± 12.30 years were enrolled. Weight, height, body mass index (BMI), waist circumference (WC), fasting glucose, basal insulin, plasma lipids, Homeostasis Model Assessment-Insulin Resistance (HOMA-IR), and 25(OH)D levels were measured. FINDRISC with WC cutoff points modified for Latin America was applied.


      No difference in 25(OH)D levels between obese and nonobese subjects was found. When anthropometric, clinical, and biochemical variables according to the 25(OH)D status were compared, the only difference detected was higher LA-FINDRISC in the insufficient/low 25(OH)D group compared to normal 25(OH)D levels group (12.75 ± 6.62; vs 10.15 ± 5.21; p = 0.031). LA-FINDRISC was negatively correlated with plasma 25(OH)D levels (r = −0.302; p = 0.002) and positively correlated with the HOMA-IR index (r = 0.637; p = 0.0001).


      The LA-FINDRISC significantly correlated with both 25(OH)D levels and insulin resistance markers in this group of patients.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Holick M.F.
        Vitamin D deficiency.
        N. Engl. J. Med. 2007; 357: 266-281
        • Lips P.
        Vitamin D physiology.
        Prog. Biophys. Mol. Biol. 2006; 92: 4-8
        • Holick M.F.
        High prevalence of vitamin D inadequacy and implications for health.
        Mayo Clin. Proc. 2006; 81: 353-373
        • Holick M.F.
        • Siris E.S.
        • Binkley N.
        • et al.
        Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy.
        J. Clin. Endocrinol. Metab. 2005; 90: 3215-3224
        • Brannon P.M.
        • Picciano M.F.
        Vitamin D in pregnancy and lactation in humans.
        Annu. Rev. Nutr. 2011; 31: 89-115
        • Hill T.R.
        • Cotter A.A.
        • Mitchell S.
        • et al.
        Vitamin D status and its determinants in adolescents from the Northern Ireland Young Hearts 2000 cohort.
        Br. J. Nutr. 2008; 99: 1061-1067
        • Saneei P.
        • Salehi-Abargouei A.
        • Esmaillzadeh A.
        Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis.
        Obes. Rev. 2013; 14: 393-404
        • Caron-Jobin M.
        • Morisset A.S.
        • Tremblay A.
        • et al.
        Elevated serum 25(OH)D concentrations, vitamin D, and calcium intakes are associated with reduced adipocyte size in women.
        Obesity (Silver Spring). 2011; 19: 1335-1341
        • Marcotorchino J.
        • Tourniaire F.
        • Astier J.
        • et al.
        Vitamin D protects again diet-induced obesity by enhancing fatty acid oxidation.
        J. Nutr. Biochem. 2014; 25: 1077-1083
        • Chiu K.C.
        • Chu A.
        • Go V.L.
        • Saad M.F.
        Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction.
        Am. J. Clin. Nutr. 2004; 79: 820-825
        • Wranicz J.
        • Szostak-Wegierek D.
        Health outcomes of vitamin D. Part II. Role in prevention of diseases.
        Rocz. Panstw. Zakl. Hig. 2014; 65: 273-279
        • Lindstrom J.
        • Tuomilehto J.
        The diabetes risk score: a practical tool to predict type 2 diabetes risk.
        Diabetes Care. 2003; 26: 725-731
        • Aschner P.
        • Buendía R.
        • Brajkovich I.
        • et al.
        Determination of the cutoff point for waist circumference that establishes the presence of abdominal obesity in Latin American men and women.
        Diabetes Res. Clin. Pract. 2011; 93: 243-247
        • Aschner P.
        • Nieto-Martínez R.
        • Marin A.
        • Ríos M.
        Validation of the FINDRISC score as a screening tool for people with impaired glucose regulation in Latin America using modified regional cut-off points for waist circumference.
        Minerva Endocrinol. 2012; 37: 114
        • Holick M.
        • Binkley N.
        • Bischoff-Ferrari H.
        • et al.
        Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.
        J. Clin. Endocrinol. Metab. 2011; 96: 1911-1930
        • Schwarz P.E.
        • Li J.
        • Lindstrom J.
        • Tuomilehto J.
        Tools for predicting the risk of type 2 diabetes in daily practice.
        Horm. Metab. Res. 2009; 41: 86-97
        • Janghorbani M.
        • Adineh H.
        • Amini M.
        Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome.
        Rev. Diabet. Stud. 2013; 10: 283-292
        • Djurić P.
        • Mladenović Z.
        • Grdinić A.
        • et al.
        Correlation between the Finnish Diabetes Risk Score and the severity of coronary artery disease.
        Vojnosanit. Pregl. 2014; 71: 474-480
        • Makrilakis K.
        • Liatis S.
        • Grammatikou S.
        • et al.
        Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece.
        Diabetes Metab. 2011; 37: 144-151
        • Florez H.
        • Silva E.
        • Fernández V.
        • et al.
        Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black Amerindian and Mixed Hispanics in Zulia, State, Venezuela.
        Diabetes Res. Clin. Pract. 2005; 69: 63-77
        • Barter P.J.
        The causes and consequences of low levels of high density lipoproteins in patients with diabetes.
        Diabetes Metab. J. 2011; 35: 101-106
        • Song S.
        • Kim E.K.
        • Hong S.
        • et al.
        Low consumption of fruits and dairy foods is associated with metabolic syndrome in Korean adults from outpatient clinics in and near Seoul.
        Nutr. Res. Pract. 2015; 9: 554-562
        • Mattila C.
        • Knekt P.
        • Männistö S.
        • et al.
        Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes.
        Diabetes Care. 2007; 30: 2569-2570
        • Forouhi N.G.
        • Luan J.
        • Cooper A.
        • et al.
        Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000.
        Diabetes. 2008; 57: 2619-2625
        • Takiishi T.
        • Gysemans C.
        • Bouillon R.
        • Mathieu C.
        Vitamin D and diabetes.
        Rheum. Dis. Clin. North Am. 2012; 38: 179-206
        • Thorand B.
        • Zierer A.
        • Huth C.
        • et al.
        Effect of serum 25-hydroxyvitamin D on risk for type 2 diabetes may be partially mediated by subclinical inflammation: results from the MONICA/KORA Augsburg study.
        Diabetes Care. 2011; 34: 2320-2322
        • Ding C.
        • Parameswaran V.
        • Blizzard L.
        • et al.
        Not a simple fat-soluble vitamin: changes in serum 25-(OH)D levels are predicted by adiposity and adipocytokines in older adults.
        J. Int. Med. 2010; 268: 501-510
        • Matthews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • et al.
        Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
        • Schwarz P.E.
        • Li J.
        • Reimann M.
        • et al.
        The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes.
        J. Clin. Endocrinol. Metab. 2009; 94: 920-926
        • Brodovicz K.G.
        • Dekker J.M.
        • Rijkelijkhuizen J.M.
        • et al.
        The Finnish Diabetes Risk Score is associated with insulin resistance but not reduced β-cell function, by classical and model-based estimates.
        Diabet. Med. 2011; 28: 1078-1081
        • Wang J.
        • Stancáková A.
        • Kuusisto J.
        • Laakso M.
        Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men.
        J. Clin. Endocrinol. Metab. 2010; 95: 3858-3862
        • Bergmann A.
        • Li J.
        • Wang L.
        • et al.
        A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population.
        Horm. Metab. Res. 2007; 39: 677-682
        • Vanlint S.
        Vitamin D and obesity.
        Nutrients. 2013; 5: 949-956
        • Scott D.
        • Blizzard L.
        • Fell J.
        • et al.
        A prospective study of the associations between 25-hydroxyvitamin D, sarcopenia progression, and physical activity in older adults.
        Clin. Endocrinol. (Oxf.). 2010; 73: 581-587
        • Aboraia A.S.
        • Makowski B.
        • Bahja A.
        • et al.
        Synthesis and CYP24A1 inhibitory activity of (E)-2-(2-substituted benzylidene)- and 2-(2-substituted benzyl)-6-methoxy-tetralones.
        Eur. J. Med. Chem. 2010; 45: 4427-4434
        • Reis J.P.
        • von Mühlen D.
        • Kritz-Silverstein D.
        • et al.
        Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults.
        Diabetes Care. 2007; 30: 1549-1555
        • Rueda S.
        • Fernández-Fernández C.
        • Romero F.
        • et al.
        Vitamin D, PTH, and the metabolic syndrome in severely obese subjects.
        Obes. Surg. 2008; 18: 151-154
        • Reis J.P.
        • von Mühlen D.
        • Miller 3rd, E.R.
        Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults.
        Eur. J. Endocrinol. 2008; 159: 41-48
        • Miñambres I.
        • Sánchez-Hernández J.
        • Sánchez-Quesada J.L.
        • et al.
        The association of hypovitaminosis D with the metabolic syndrome is independent of the degree of obesity.
        ISRN Endocrinol. 2012; 2012: 691803
        • Carvalho J.A.
        • Barengo N.C.
        • Tuomilehto J.
        • et al.
        The Finnish Diabetes Risk Score (FINDRISC) as a screening tool for hepatic steatosis.
        Ann. Med. 2011; 43: 487-494